Welcome > Support > Âü°íÀÚ·á  
 
 
E
 
±Ûº¸±â
¼º¸í ÆijªÁø     (Date : 2011-05-16 13:45:39)
Á¦¸ñ [³í¹®] [Clamp]Rapid and Sensitive Detection of KRAS Mutation by Peptide Nucleic Acid-based Real-time PCR Clamping: A Comparison with Direct Sequencing between Fresh Tissue and Formalin-fixed and Paraffin Embedded Tissue of Colorectal Cancer
³»¿ë

The Korean Journal of Pathology 2011; 45: 151-159
DOI: 10.4132/KoreanJPathol.2011.45.2.151

Rapid and Sensitive Detection of KRAS Mutation by Peptide Nucleic Acid-based Real-time PCR Clamping: A Comparison with Direct Sequencing between Fresh Tissue and Formalin-fixed and Paraffin Embedded Tissue of Colorectal Cancer


Dongjun Jeong¡¤Yujun JeongJonghyun Lee1¡¤Moo-Jun Baek2Yongbae Kim3¡¤Ji-Hye LeeHyun-Deuk Cho¡¤Mee-Hye OhChang-Jin Kim

Abstract
Background: Rapid and sensitive detection of KRAS mutation is needed to maximize the benefits for patients who are being treated with monoclonal antibodies to target the epidermal growth factor receptor in colorectal cancer. The aim of this study is to evaluate the efficacy of the peptide nucleic acid clamp real-time PCR (PCqPCR) as compared to that of direct sequencing (DS) between using fresh colorectal cancer tissue and the matched formalin-fixed and paraffin-embedded (FFPE) colorectal cancer tissue. Methods: The efficacy of PCqPCR was evaluated and compared with that of DS using fresh tissue and matched FFPE tissue from 30 cases of colorectal cancer. Results: PCqPCR is more sensitive than DS for detecting KRAS mutation. PCqPCR detected 1% of mutants in 1 ng DNA. PCqPCR detected mutation in 1% of mutant cells, while DS barely detected, by manual reading, that in 20-50% of mutant cells. In the clinical samples, PCqPCR detected KRAS mutation in 60.0% while DS detected KRAS mutation in 53.3% of the colorectal cancers. The two methods showed a 100% concordance rate for detecting KRAS mutation between the fresh tissue and FFPE tissue. Conclusions: The PCqPCR method is efficiently applicable for the detection of KRAS mutation in a clinical setting.

Keywords Sequencing; DNA; Peptide nucleic acids; Polymerase chain reaction; Colorectal neoplasms; KRAS gene


 

 ¹øÈ£   Á¦¸ñ ÀÛ¼ºÀÚ ÆÄÀÏ Á¶È¸
   49           [³í¹®] [2016]Comparison of EGFR .. ÆijªÁø 30429
   48           [³í¹®] [2015]IDH Mutation Analys.. ÆijªÁø 65535
   47           [³í¹®] [2015]Low frequency of KR.. ÆijªÁø 29336
   46           [³í¹®] [2015]Simultaneous genoty.. ÆijªÁø 6194
   45           [³í¹®] [2014]Simultaneous diagno.. ÆijªÁø 21100
   44           [³í¹®] [2014]KRAS Mutation Detec.. ÆijªÁø 8541
   43           [³í¹®] [2013]Detection of EGFR m.. ÆijªÁø 1300
   42           [³í¹®] [2013]Detection and compa.. ÆijªÁø 5942
   41           [³í¹®] [2013]Detection of BRAF V.. ÆijªÁø 6224
   40           [³í¹®] [2013]Comparison of Direc.. ÆijªÁø 25411
   39           [³í¹®] [Microarray]Peptide nucle.. ÆijªÁø 14448
¢º           [³í¹®] [Clamp]Rapid and Sensitiv.. ÆijªÁø 22368
   37           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] EGFR µ¹¿¬º¯.. ÆijªÁø 3513
   36           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] Development .. ÆijªÁø 14284
   35           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] JHDM3A modul.. ÆijªÁø 1292
   34           [³í¹®] [PNA Chip vs DNA Chip ÀÓ»ó.. ÆijªÁø 4154
   33           [³í¹®] [ÆijªÁø ³í¹®¹ßÇ¥] PNA-mediated Re.. ÆijªÁø 8948
   32           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡.. ÆijªÁø 14603
   31           [³í¹®] [ÆijªÁø ³í¹® ¹ßÇ¥] PNA-Based Anti.. ÆijªÁø 1296
   30           [³í¹®] [ÆijªÁø ³í¹®¹ßÇ¥]Peptide nucleic .. ÆijªÁø 4018
 

< 1 2 3 >